Avicanna Inc. AVCNF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

36/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Avicanna Inc. (AVCNF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 34/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

36/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

33/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

35/100

→ Income

✓

成长

100/100

→ Income

✗

收入

10/100

→ Income

估值概览 — AVCNF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.45

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.04

每股账面价值$0.00

每股营收$0.25

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2016	$0.00	$0.00	$-29.83K	-
2017	$-0.19	$26.66K	$-2.6M	-9750.5%
2018	$-0.45	$117.97K	$-7.1M	-6017.6%
2019	$-1.05	$168.25K	$-21.07M	-12524.1%
2020	$-1.12	$1.57M	$-32.86M	-2093%
2021	$-0.41	$3.27M	$-16.77M	-513.2%
2022	$-0.25	$4.05M	$-14.74M	-364%
2023	$-0.10	$16.79M	$-8.74M	-52.1%
2024	$-0.04	$25.46M	$-3.62M	-14.2%